Skip to main content
OpenTrials

Clinical trial condition

Primary Immunodeficiency Diseases

Explore clinical trials studying Primary Immunodeficiency Diseases. Study availability and eligibility vary by location and protocol.

254 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Primary Immunodeficiency Diseases trial results

Completed

PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial

NCT05511922

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • KalVista Investigative Site Scottsdale, Arizona, United States
  • KalVista Investigative Site Little Rock, Arkansas, United States
  • KalVista Investigative Site San Diego, California, United States
  • KalVista Investigative Site San Diego, California, United States
View all 61 locations
View Trial Details
Completed

An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

NCT05505916

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • KalVista Investigative Site Scottsdale, Arizona, United States
  • KalVista Investigative Site Little Rock, Arkansas, United States
  • KalVista Investigative Site San Diego, California, United States
  • KalVista Investigative Site San Diego, California, United States
View all 71 locations
View Trial Details
Completed

CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema

NCT05819775

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Research Solutions of Arizona Litchfield Park, Arizona, United States
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • Donald S. Levy M.D. Orange, California, United States
  • Raffi Tachdjian MD, Inc. Santa Monica, California, United States
View all 13 locations
View Trial Details
Completed

Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks

NCT04739059

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Research Solutions of Arizona Litchfield Park, Arizona, United States
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • Little Rock Allergy & Asthma Clinic Little Rock, Arkansas, United States
View all 44 locations
View Trial Details
Completed

Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous

NCT02320357

Conditions
Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dysgammaglobulinemia, +8 more
Locations
  • Service de Médecine Interne et maladies Infectieuses - Hôpital Saint-André Bordeaux, France
  • Service de Médecine Interne Limoges, France
  • Service de Médecine Interne et Immunopathologie Toulouse, France
View Trial Details
Completed

An Extension Study of Donidalorsen (IONIS-PKK-LRx) in Participants With Hereditary Angioedema

NCT04307381

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Ionis Investigative Site Scottsdale, Arizona, United States
  • Ionis Investigative Site Santa Monica, California, United States
  • Ionis Investigative Site Plymouth, Minnesota, United States
  • Ionis Investigative Site Cincinnati, Ohio, United States
View Trial Details
Completed

A Study of Navenibart (STAR-0215) in Participants With Hereditary Angioedema

NCT05695248

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Allervie Clinical Research Birmingham, Alabama, United States
  • Medical Research of Arizona a Division of Allergy, Asthma & Immunology Associates, LTD. Scottsdale, Arizona, United States
  • Allergy & Asthma Clinic of Northwest Arkansas Bentonville, Arkansas, United States
  • Acuro Research, Inc. Little Rock, Arkansas, United States
View all 20 locations
View Trial Details
Completed

Evaluate the Neurological Effects of EryDex on Subjects With A-T

NCT06193200

Conditions
Ataxia, Ataxia Telangiectasia, Brain Diseases, +19 more
Locations
  • University of California Los Angeles (UCLA), Ataxia Center and HD Center of excellence Los Angeles, California, United States
  • The Johns Hopkins Hospital, Division of pediatric allergy and immunology Baltimore, Maryland, United States
  • Cincinnati Children's Hospital, Division of neurology Cincinnati, Ohio, United States
  • UT Health Houston, Department of pediatrics, division of child & adolescent neurology Houston, Texas, United States
View all 19 locations
View Trial Details
Completed

Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector

NCT01129544

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +9 more
Locations
  • Mattel Children's Hospital - UCLA Los Angeles, California, United States
  • Children's Hospital Boston Boston, Massachusetts, United States
  • Cincinnati Children's Medical Center Cincinnati, Ohio, United States
View Trial Details

Related conditions